Ken Opeskin

979 total citations
20 papers, 742 citations indexed

About

Ken Opeskin is a scholar working on Psychiatry and Mental health, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Ken Opeskin has authored 20 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Psychiatry and Mental health, 4 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Ken Opeskin's work include Neuroscience and Neuropharmacology Research (4 papers), Mitochondrial Function and Pathology (3 papers) and Cancer Genomics and Diagnostics (3 papers). Ken Opeskin is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), Mitochondrial Function and Pathology (3 papers) and Cancer Genomics and Diagnostics (3 papers). Ken Opeskin collaborates with scholars based in Australia, United States and South Korea. Ken Opeskin's co-authors include Colin L. Masters, Joseline Ojaimi, Kylie L. Gorringe, Ian Campbell, Ella R. Thompson, David Copolov, Brian Dean, Stephen B. Fox, Michael Burke and Wen Qiu and has published in prestigious journals such as Nature Genetics, Annals of Neurology and Clinical Cancer Research.

In The Last Decade

Ken Opeskin

19 papers receiving 721 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Opeskin Australia 11 355 201 175 112 104 20 742
Lisa I. Greene United States 6 325 0.9× 159 0.8× 113 0.6× 75 0.7× 89 0.9× 6 746
Myrthala Moreno‐Smith United States 11 311 0.9× 229 1.1× 147 0.8× 247 2.2× 125 1.2× 15 843
David Bargiela United Kingdom 17 412 1.2× 180 0.9× 173 1.0× 42 0.4× 150 1.4× 30 855
Elizabeth Matthew United States 15 260 0.7× 182 0.9× 66 0.4× 79 0.7× 157 1.5× 29 676
Yaroslav Teper United States 10 346 1.0× 206 1.0× 98 0.6× 65 0.6× 123 1.2× 16 762
Pachiappan Manickam United States 18 334 0.9× 444 2.2× 60 0.3× 65 0.6× 164 1.6× 24 1.2k
R. Christian Crumrine United States 14 356 1.0× 122 0.6× 69 0.4× 39 0.3× 222 2.1× 19 904
Archana S. Nagaraja United States 14 356 1.0× 280 1.4× 166 0.9× 392 3.5× 137 1.3× 22 1.1k
GK Stalla Germany 18 247 0.7× 119 0.6× 100 0.6× 27 0.2× 68 0.7× 36 938
R.R. Frants Netherlands 19 396 1.1× 349 1.7× 229 1.3× 336 3.0× 118 1.1× 33 1.1k

Countries citing papers authored by Ken Opeskin

Since Specialization
Citations

This map shows the geographic impact of Ken Opeskin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Opeskin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Opeskin more than expected).

Fields of papers citing papers by Ken Opeskin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Opeskin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Opeskin. The network helps show where Ken Opeskin may publish in the future.

Co-authorship network of co-authors of Ken Opeskin

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Opeskin. A scholar is included among the top collaborators of Ken Opeskin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Opeskin. Ken Opeskin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gorringe, Kylie L., Sally M. Hunter, Jia‐Min Pang, et al.. (2015). Copy number analysis of ductal carcinoma in situ with and without recurrence. Modern Pathology. 28(9). 1174–1184. 31 indexed citations
2.
Gorringe, Kylie L., Ella R. Thompson, Ken Opeskin, et al.. (2011). Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma. Breast Cancer Research and Treatment. 133(3). 889–898. 51 indexed citations
3.
4.
Keks, Nicholas A, Christine Hill, Suresh Sundram, et al.. (2009). Evaluation of Treatment in 35 Cases of Bipolar Suicide. Australian & New Zealand Journal of Psychiatry. 43(6). 503–508. 17 indexed citations
5.
Qiu, Wen, Min Hu, Anita Sridhar, et al.. (2008). No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Nature Genetics. 40(5). 650–655. 228 indexed citations
6.
Jellis, Christine, Andrew I. MacIsaac, Ken Opeskin, & Stephen Schlicht. (2008). Pulmonary Valve Papillary Fibroelastoma. Heart Lung and Circulation. 18(5). 360–361. 2 indexed citations
7.
Holloway, Andrew, Dileepa Diyagama, Ken Opeskin, et al.. (2006). A Molecular Diagnostic Test for Distinguishing Lung Adenocarcinoma from Malignant Mesothelioma Using Cells Collected from Pleural Effusions. Clinical Cancer Research. 12(17). 5129–5135. 29 indexed citations
8.
Tomaskovic‐Crook, Eva, et al.. (2000). Serotonin2A receptors are reduced in the planum temporale from subjects with schizophrenia. Schizophrenia Research. 44(1). 35–45. 31 indexed citations
9.
Burke, Michael & Ken Opeskin. (2000). Audit in Forensic Pathology. American Journal of Forensic Medicine & Pathology. 21(3). 230–236. 7 indexed citations
10.
Ojaimi, Joseline, et al.. (1999). Mitochondrial respiratory chain activity in the human brain as a function of age. Mechanisms of Ageing and Development. 111(1). 39–47. 128 indexed citations
11.
Opeskin, Ken, Michael Burke, Stephen Cordner, & Samuel F. Berkovic. (1999). Comparison of Antiepileptic Drug Levels in Sudden Unexpected Deaths in Epilepsy with Deaths from Other Causes. Epilepsia. 40(12). 1795–1798. 63 indexed citations
12.
Ojaimi, Joseline, Colin L. Masters, Catriona McLean, et al.. (1999). Irregular distribution of cytochrome c oxidase protein subunits in aging and Alzheimer's disease. Annals of Neurology. 46(4). 656–660. 1 indexed citations
13.
Silberstein, Morry, et al.. (1999). Spinal Schmorl’s nodes: Sagittal sectional imaging and pathological examination. Australasian Radiology. 43(1). 27–30. 9 indexed citations
14.
Ojaimi, Joseline, Colin L. Masters, Catriona McLean, et al.. (1999). Irregular distribution of cytochromec oxidase protein subunits in aging and Alzheimer's disease. Annals of Neurology. 46(4). 656–660. 47 indexed citations
15.
16.
Opeskin, Ken. (1998). The Neuropathology of Head Injury. 161–188. 1 indexed citations
17.
Roberts, Susan B., Christine Hill, Brian Dean, et al.. (1998). Confirmation of the Diagnosis of Schizophrenia after Death Using DSM-IV: A Victorian Experience. Australian & New Zealand Journal of Psychiatry. 32(1). 73–76. 67 indexed citations
18.
Roberts, Susan B., Christine Hill, Brian Dean, et al.. (1998). Confirmation of the diagnosis of schizophrenia after death using DSM-IV: a Victorian experience. Australian & New Zealand Journal of Psychiatry. 32(1). 73–76. 8 indexed citations
19.
20.
Keks, Nicholas A, Christine Hill, Brian Dean, et al.. (1997). Diagnostic instrument for brain studies (DIBS). Schizophrenia Research. 24(1-2). 34–34. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa I. Greene Breakdown of academic impact, for papers by Myrthala Moreno‐Smith Breakdown of academic impact, for papers by David Bargiela Breakdown of academic impact, for papers by Elizabeth Matthew Breakdown of academic impact, for papers by Yaroslav Teper Breakdown of academic impact, for papers by Pachiappan Manickam Breakdown of academic impact, for papers by R. Christian Crumrine Breakdown of academic impact, for papers by Archana S. Nagaraja Breakdown of academic impact, for papers by GK Stalla Breakdown of academic impact, for papers by R.R. Frants
Rankless by CCL
2026